PGR and breast cancer: BC is histologically classified into four subtypes based on the expression levels of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), i.e., luminal A, luminal B, triple-negative (TNBC), and HER2-positive [4,5,6].